|
|
|
|
CD20
|
| |
|
| |
CD20 is a non-glycosylated phosphoprotein expressed on the surface of all mature B-cells.
Membrane-spanning 4-domains, subfamily A, member 1, also known as MS4A1, is a human gene.
protein has no known natural ligand and its function is unclear. It is suspected that it acts as a calcium channel in the cell membrane.
is expressed on all stages of B cell development except the first and last; it is present from pre-pre B cells through memory cells, but not on either pro-B cells or plasma cells.
It is found on B-cell lymphomas, hairy cell leukemia, and B-cell chronic lymphocytic leukemia.

Discussion
Ask a question about 'CD20'
Start a new discussion about 'CD20'
Answer questions from other users
|
Encyclopedia
CD20 is a non-glycosylated phosphoprotein expressed on the surface of all mature B-cells.
Membrane-spanning 4-domains, subfamily A, member 1, also known as MS4A1, is a human gene.
Function
The protein has no known natural ligand and its function is unclear. It is suspected that it acts as a calcium channel in the cell membrane.
Expression
CD20 is expressed on all stages of B cell development except the first and last; it is present from pre-pre B cells through memory cells, but not on either pro-B cells or plasma cells.
It is found on B-cell lymphomas, hairy cell leukemia, and B-cell chronic lymphocytic leukemia. It is also found on skin/melanoma cancer stem cells.
Clinical significance
It is the target of the monoclonal antibodies rituximab, Ibritumomab tiuxetan, and tositumomab, which are all active agents in the treatment of all B cell lymphomas and leukemias. Additional antibody therapeutics under development (phase II or III clinical trials) include AME-133v (Applied Molecular Evolution), Ocrelizumab (Roche), Ofatumumab (Genmab), TRU-015 (Trubion) and IMMU-106 (Immunomedics).
FMC7 appears to be a conformational variant.
Further reading
External links
- representations of the shape are found and more detail
|
| |
|
|